Thiarabine

Related by string. * * ProLindac MuGard Thiarabine *

Related by context. All words. (Click for frequent words.) 84 generation nucleoside analog 80 novel nucleoside analog 73 CYT# potent vascular disrupting 73 liposomal formulation 72 telomerase therapeutic 72 Panzem R 71 orally administered inhibitor 71 Xanafide 71 ocular formulation 71 refractory chronic lymphocytic 71 proteasome inhibitor 71 PNP inhibitor 70 metaglidasen 70 targeted radiotherapeutic 70 LymphoStat B TM 70 LymphoStat B belimumab 70 Dapagliflozin 70 PI3K/Akt pathway inhibitor 70 radiation sensitizer 70 Bucindolol 70 drug pipeline TAFA# 70 XL# anticancer compounds 70 rxRNA 70 TKB# 70 Completes Patient Enrollment 70 Alfacell proprietary ribonuclease 69 erlotinib Tarceva ® 69 Xcellerated T Cells 69 Voreloxin 69 targeting CD# 69 Glufosfamide 69 Onconase 69 GVAX ® 69 novel VDA molecule 69 non nucleoside inhibitor 69 Novel Oral 69 HGS ETR1 mapatumumab 69 Meets Primary Endpoint 69 volociximab 69 selective orally bioavailable 69 multi kinase inhibitor 69 Tezampanel 69 protein tyrosine phosphatase 1B 69 demonstrated antitumor activity 69 oncolytic virus therapies 69 evaluating tivozanib 69 Epratuzumab 69 PDE4 inhibitor 69 JAK1 69 VEGFR2 inhibitor 69 ALN TTR# 69 acetonide FA 69 ENMD # 68 CYP#A# CYP#D# 68 anti amnesic 68 developing Bicifadine serotonin 68 PEGylated anti 68 TNF Tumor Necrosis Factor 68 2 methoxyestradiol 68 sodium glucose cotransporter 68 HQK 68 pathophysiological effects 68 THR beta agonist 68 CTAP# Capsules 68 bevacizumab Avastin ® 68 Bezielle 68 alvespimycin 68 Factor VIIa 68 Presents Preclinical Data 68 introduced NEUGENE 68 IAP inhibitor 68 selective kinase inhibitor 68 YONDELIS 68 Symadex 68 5 FU leucovorin 68 AAG geldanamycin analog 68 hyaluronidase enzyme 68 ATRA IV 68 essential thrombocythemia ET 68 PEGylated Fab fragment 68 HuMax 68 sunitinib Sutent ® 68 TRAIL R2 68 MAGE A3 ASCI 68 modified glutathione analog 68 HuMax CD#b 68 oral prodrug 68 Initiates Enrollment 68 Annamycin 68 oral ghrelin agonist 68 humanized anti 68 acyclovir Lauriad R 68 delivers fluocinolone acetonide FA 68 targeted antifolate 68 Safinamide 68 Nexavar sorafenib 68 cetuximab Erbitux R 68 dasatinib Sprycel 68 Fc fusion protein 68 Hsp# Inhibitor 68 aldehyde dehydrogenase ALDH2 deficiency 68 PEGylated interferon 68 brand ciclesonide HFA 68 Serostim ® 68 Phase #b/#a clinical 68 CCX# 68 Letairis ambrisentan 68 novel histone deacetylase 68 HuMax EGFr 67 NASH Huntington 67 vidofludimus 67 Bafetinib 67 PD LID 67 Omacetaxine 67 Nexavar sorafenib tablets 67 reslizumab 67 Oral NKTR 67 Locked Nucleic Acid 67 FOLFOX6 chemotherapy regimen 67 HER2 ErbB2 67 Aplidin R 67 CBLC# 67 Fludara ® 67 vinorelbine tartrate 67 MKC# MKC# PP 67 Leukine ® 67 Aflibercept 67 OXi# 67 cathepsin K inhibitor 67 mertansine 67 Personalized Immunotherapy 67 alpha folate receptor 67 Azedra 67 mTOR inhibitor 67 Myocet 67 Curaxin CBLC# 67 Antitumor Activity 67 huC# DM4 67 paclitaxel Taxol ® 67 thalidomide Thalomid 67 Vidaza ® 67 Fleximer 67 ospemifene 67 Albuferon TM 67 vapreotide acetate 67 PEG SN# 67 AEG# 67 antiangiogenic activity 67 Quinamed 67 MKC# MT 67 NS5B polymerase 67 sorafenib tablets 67 Ophena 67 Mipomersen 67 topically applied SEPA 67 candidates Azedra TM 67 stable nucleic acid 67 Aplidin 67 agonistic human 67 pan HDAC inhibitor 67 formerly LymphoStat B 67 Pertuzumab 67 irinotecan doxorubicin oxaliplatin paclitaxel 67 Pegasys ® 67 MT#/MEDI-# 67 receptor tyrosine kinase inhibitor 67 bevacizumab Avastin R 67 Epidermal Growth Factor Receptor 67 lenalidomide Revlimid R 67 nilotinib Tasigna 67 Besivance 67 Dasatinib 67 erlotinib Tarceva R 67 Tarceva TM 67 SPRYCEL ® 67 TRAIL receptor antibodies 67 Phase 2b Clinical Trial 67 metastatic colorectal 67 catheter occlusion 67 Ocrelizumab 67 trastuzumab Herceptin R 67 small molecule thrombopoietin 67 dimebon latrepirdine 67 BZL# 67 HuMax TAC 67 DNA methyltransferase inhibitors 67 product Fentanyl TAIFUN 67 HuMax Wnt 67 nucleoside analog 67 somatostatin analogue 67 RhuDex R 67 anti CD3 67 kidney urologic 67 TRO# 67 lintuzumab SGN 67 Cloretazine ® 67 Initiates Phase II 67 imatinib Gleevec ® 67 MYDICAR ® 67 IMA# 66 HGS# 66 Locked Nucleic Acid LNA 66 Preclinical Study 66 sorafenib Nexavar 66 Previously Untreated 66 Study Evaluating 66 Initiate Phase 66 oral isoform selective HDAC 66 IMPDH inhibitor 66 Panzem R NCD 66 hypereosinophilic syndrome 66 Patients Treated With 66 Vicriviroc 66 Combination REOLYSIN R 66 pralatrexate injection folate analogue 66 Daclizumab 66 Provectus Pharmaceuticals specializes 66 Curaxin 66 virus HCV protease inhibitor 66 methylnaltrexone bromide 66 R sorafenib tablets 66 dasatinib Sprycel ® 66 Solazed TM 66 CD# CEA 66 Ceflatonin R 66 TRAIL R1 66 CCR9 antagonist 66 BCG refractory carcinoma 66 TNF alpha selectively neutralizing 66 HuCAL PLATINUM ® CysDisplay 66 TBC# 66 personalized cellular immunotherapy 66 Janus kinase 66 Drug Candidate 66 ALN PCS 66 Biolimus A9 66 oral picoplatin 66 ALN TTR 66 Xeloda ® 66 PRT# 66 Bayer HealthCare Onyx Pharmaceuticals 66 omacetaxine mepesuccinate 66 First Patient Dosed 66 rusalatide acetate 66 iobenguane 66 IMiDs ® 66 chronic eosinophilic leukemia 66 Tesetaxel 66 Vicinium TM 66 oral proteasome inhibitor 66 Locteron ® 66 TRANSDUR ® 66 UltiMAb TM 66 peptidic compound 66 anionic backbone 66 vaccine GRNVAC1 66 DCVax R 66 Alocrest 66 gastrin analogue TT 66 CIMZIA ™ 66 Archexin 66 trastuzumab DM1 T DM1 66 oral dual endothelin 66 including eniluracil ADH 66 MTP inhibitor 66 sarcoma melanoma 66 novel synthetic peptide 66 Panzem NCD 66 Liposomal 66 cMET 66 DNA intercalator 66 Begins Dosing 66 INCB# [001] 66 generation purine nucleoside 66 anti CD3 monoclonal 66 TELINTRA R 66 Achieves Primary Endpoint 66 Excellarate TM 66 leukemia AML 66 MT# MEDI 66 Rigel R# 66 small molecule tyrosine 66 accumulate preferentially 66 orally bioavailable 66 TO AVOID PREGNANCY WHILE 66 PSMA ADC 66 OHR/AVR# 66 histone deacetylase HDAC inhibitor 66 Vidaza R 66 LHRH antagonist 66 Phase 1b clinical trials 66 sodium thiosulfate STS 66 Zorbtive TM 66 pan histone deacetylase 66 Aurora Kinase 66 allosteric modulator NAM 66 Mg Usa 66 MGd 66 tumor activated prodrug 66 Elagolix 66 AQD class 66 highly selective inhibitor 66 depsipeptide 66 oral dihydropyrimidine dehydrogenase DPD 66 investigational pan BCR 66 proprietary BiTE ® 66 recurrent metastatic ovarian cancer 66 Aganocide ® 66 Kahalalide F 66 therapeutic monoclonal antibody 66 ADP receptor antagonist 66 dependent kinase inhibitor 66 antibody MAb 66 Prolongs Survival 66 anti angiogenic agent 66 pertuzumab 66 next generation URAT1 66 XOMA 3AB 66 PEGylated 66 CDK cyclin dependent 66 ProSavin 66 intranasal formulation 66 novel topoisomerase 66 Telatinib 66 Dural Regeneration Matrix 66 Peginterferon alfa 2b 66 DURECT proprietary 66 Harbor BioSciences 65 selective inhibition 65 oral chemotherapeutic agent 65 vinca alkaloid 65 docetaxel Taxotere R 65 Randomized Phase 65 Factor Receptor 65 Zolinza 65 GRNVAC1 65 rHuPH# recombinant human 65 selective androgen receptor modulator 65 Delafloxacin 65 Racivir 65 Ribavirin causes 65 KSP inhibitor 65 Ridaforolimus 65 TRANSDUR ™ 65 xenograft models 65 gefitinib Iressa 65 Luteinizing Hormone Releasing Hormone 65 hA# 65 Initiate Clinical Trial 65 oral nucleoside analogue 65 Gleevec imatinib mesylate 65 Telik logo TELINTRA 65 oral Factor Xa 65 PF # [002] 65 paclitaxel poliglumex 65 luteinizing hormone releasing 65 Crofelemer budesonide foam 65 acute peripheral arterial 65 product candidate Lpathomab 65 platinum chemotherapeutic 65 topical gel formulation 65 Angiocept 65 tumor xenograft models 65 CRTH2 65 Intravenous Human 65 Pimavanserin 65 RGB # 65 Kinase Inhibitor 65 Nventa proprietary CoVal 65 humanized antibody 65 OMNARIS HFA 65 RhuDex ® 65 Azacitidine 65 metastatic hormone refractory 65 CINQUIL 65 OvaRex R 65 seliciclib CYC# 65 humanized monoclonal 65 TTR amyloidosis 65 delta opioid receptor 65 Pentraxin 2 65 corticosteroid dexamethasone 65 BENLYSTA TM 65 DCVax ® 65 HCV RNA polymerase 65 docetaxel Taxotere ® 65 LPA1 receptor 65 mGluR2 NAM 65 tiapamil 65 Recombinant Human 65 apomorphine hydrochloride 65 HuMax HepC 65 Temsirolimus 65 MET amplification 65 FOLOTYN ® 65 Presents Preclinical 65 liposomal doxorubicin 65 recombinant adeno associated 65 protein kinase inhibitor 65 treat male hypogonadism 65 Squalamine 65 Anavex #-# 65 Monoclonal Antibody 65 miconazole Lauriad ® 65 prostone 65 Tumour Vascular Disrupting Agent 65 IMiD 65 Monoclonal 65 A1PI 65 Reports Preclinical Data 65 Phase IIb Trial 65 nucleoside analogue 65 Tocilizumab 65 NeuroSTAT ® 65 R Saizen R 65 indolent follicular non 65 P#X# antagonist 65 Janus Kinase 65 BXT # 65 PKC# 65 Soliris eculizumab 65 Xelox 65 Epigenomics proprietary 65 Campath alemtuzumab 65 hypoxia selective 65 IgG1 monoclonal antibody 65 BRAF inhibitor 65 immunotherapeutic agent 65 metastatic castration resistant 65 preclinical efficacy 65 Advanced Renal Cell 65 HGS ETR1 65 Vascugel 65 systemic anaplastic large 65 Sapacitabine 65 JAK2 inhibitor 65 relapsed MM 65 carcinoma HCC 65 bucindolol hydrochloride 65 FUSILEV ® 65 Pazopanib 65 Epothilone D 65 Xenograft 65 humanized interleukin 6 65 investigational humanized monoclonal antibody 65 TNFerade TM 65 Medoxomil 65 S1P antibody 65 Initiates Clinical 65 occlusion PAO 65 BRIM3 65 Ostabolin C TM 65 Romiplostim 65 PDGF receptor 65 systemically administered 65 selective modulator 65 ELACYT 65 anti EGFR antibody 65 telomerase inhibitor drug 65 NYSE Amex PBTH 65 neuroprotective properties 65 Vidofludimus 65 SinuNase ™ 65 sunitinib Sutent 65 molecular imaging radiopharmaceutical 65 MEK Inhibitor 65 DXL# 65 RAV# 65 Anticalin R 65 GW# [003] 65 JAK inhibitors 65 GeneICE 65 product platforms AZX# 65 humanized monoclonal antibodies 65 OMP #M# 65 signal transduction inhibitor 65 bortezomib Velcade R 65 ® bortezomib 65 DermaVir Patch 65 non nucleoside 65 somatostatin analog 65 non porcine pancreatic 65 DexaSite 65 RNAi Therapeutic 65 TRIOLEX HE# APOPTONE HE# 65 Panzem 65 induced macular edema 65 DOS# 65 refractory gout 65 cediranib 65 cetuximab Erbitux ® 65 IRX 2 65 Pivotal Phase III 65 LEUKINE 65 KNS # 65 Epothilones 65 Tyrosine Kinase Inhibitor 65 Cardium Therapeutics TM 65 polymerase inhibitor 65 Severe Sepsis 65 capecitabine Xeloda 65 Litx 65 Phase 2a Clinical Trial 65 Nexavar ® 65 nucleotide analogue 65 Ofatumumab 65 Interferon Alpha 65 Multimeric 65 pegylated liposomal doxorubicin 65 TRACON Pharmaceuticals 65 NPC 1C 65 AVASTIN 65 SUPPRELIN R LA 65 Degarelix 65 MKC# 65 AKT inhibitor 65 Sym# 65 Hormone Refractory Prostate Cancer 64 Onalta 64 multigene expression test 64 GAMMAGARD 64 mRNA antagonists 64 R lenalidomide 64 vivo validation 64 include VALSTAR TM 64 small molecule Hedgehog 64 Cannabinor 64 leading oral taxane 64 Files IND 64 CCX# B 64 YONDELIS R 64 LungAlert TM 64 Darinaparsin 64 XmAb# 64 fosbretabulin 64 BHT DNA 64 prescribed proton pump 64 CYC# 64 Guanilib 64 mild vasodilator 64 Pivotal Phase 64 Cobalamin TM 64 SPL# Gel vaginal microbicide 64 SYN# 64 basal bolus regimen 64 Myolimus 64 trial evaluating PRX# 64 Aliskiren 64 2 inhibitor CYT# 64 class anticancer quinolone 64 systemic juvenile idiopathic 64 PATHFINDER ® TRACER 64 ESPRIT therapy 64 DXL TM 64 FDA APPROVES 64 Micromet proprietary BiTE 64 alfa 2a 64 Oral Fingolimod 64 Interferon beta 64 relapsed leukemia 64 CDK inhibitor 64 TKM PLK1 64 anticancer compound 64 interferon gamma 1b 64 investigational pharmacologically unique 64 Symbioscience WISDOM PANEL 64 EndoTAG TM 64 potent inhibitor 64 Amrubicin 64 HuMax TF 64 metastatic malignant 64 Receives Orphan Drug Designation 64 Trastuzumab 64 compound PMX # 64 sunitinib malate 64 TÎ ² 4 64 HCV NS5B polymerase 64 Pancreate 64 XYOTAX TM 64 KL4 Surfactant 64 Emollient Foam 64 PORxin TM platforms 64 Zalypsis 64 evaluating picoplatin 64 lexidronam injection 64 Panzem ® 64 candidates Azedra 64 Amplimexon 64 selective A2A adenosine receptor 64 Phase Ib IIa 64 Adjuvant Treatment 64 HepaMate 64 Maribavir 64 pharmacological chaperone 64 polyglutamate 64 chemotherapy FOLFOX 64 antiangiogenesis therapies 64 Imprime PGG ® 64 Elotuzumab 64 OXIGON 64 cyclin dependent kinase inhibitor 64 Phase 2b Trial 64 TLK# 64 Silodosin 64 ALN VSP 64 Tengion Neo Bladder Augment 64 tumors GIST 64 mGluR5 negative 64 myelofibrosis polycythemia vera 64 neuronal nicotinic receptor NNR 64 diarrhea predominant irritable 64 ABLYNX 64 TAFA# 64 HuLuc# 64 Vandetanib 64 candidate CRLX# 64 Demonstrates Significant 64 LEX System 64 resistant hormone refractory 64 K ras mutations 64 Iluvien ® 64 highly selective adenosine 64 Anti Tumor 64 humanized monoclonal antibody 64 Seliciclib 64 selective agonist 64 TRIOLEX HE# 64 paclitaxel Taxol 64 Eculizumab 64 5 HT2A serotonin 64 antisense drug 64 OncoVEX GM CSF 64 sapacitabine CYC# 64 Mg Uk 64 RNAi therapeutic targeting PCSK9 64 delafloxacin 64 small molecule glucokinase 64 Clolar ® 64 HuMax CD# 64 PORxin TM 64 proprietary polysaccharide 64 IAP inhibitors 64 novel peptide 64 OMP #R# 64 Investigational eFlow Nebulizer System 64 targets Galectin receptors 64 Aptamer 64 Ovitrelle R Serostim 64 nilotinib Tasigna ® 64 metastatic gastric 64 5 fluorouracil leucovorin 64 SinuNase TM 64 LEAPS TM 64 metastatic neuroendocrine tumors 64 triggers apoptosis programmed 64 HGS ETR2 64 soluble tumor necrosis 64 MSCRAMM ® 64 delivery polymer matrix 64 proprietary PEGylation 64 AFREZZA TM 64 MVA BN R 64 Quinamed R 64 VitiGam 64 forodesine 64 XmAb ™ 64 Preclinical studies suggest 64 GRN# 64 R#/MEM # 64 Luveris R Ovidrel R 64 anti fibrotic 64 investigational integrase inhibitor 64 human IgG1 monoclonal 64 R roscovitine 64 Exherin TM 64 etanercept Enbrel 64 EZN 64 GTC recombinant form 64 Orally administered 64 Fodosine 64 HER1 64 Ceflatonin 64 D aspartate NMDA receptor 64 POTELLIGENT ® 64 stromal cells MSCs 64 Fludarabine 64 Carfilzomib 64 AdVac ® 64 polymerase inhibitors 64 experimental immunotherapeutics antivirals AmpligeGI mucosa resulting 64 BRIM2 64 PRN FDA Approves 64 LE SN# 64 PDE4 modulators 64 entinostat 64 Aurora kinase 64 Belerofon 64 HSP# inhibitor 64 vitreoretinal disorders 64 HuCAL GOLD R 64 TELINTRA 64 Cleviprex TM clevidipine 64 vaccine ChronVac C 64 OncoVEX 64 receptor modulators 64 pentadentate logo R 64 Lipid Polymer Micelle LPM 64 Troxatyl 64 Genotyping Test 64 Irinotecan 64 Potelligent TM 64 DAVANAT 64 selective antagonist 64 histone deacetylase inhibitor 64 Trabectedin 64 secretory phospholipase A2 sPLA2 64 vaccines oncolytic virus 64 peptide conjugated 64 ABL inhibitor 64 Zoraxel 64 OXIGON TM 64 vascular disrupting agent 64 methionine aminopeptidase 64 gemcitabine Gemzar R 64 small molecule activators 64 metastatic castrate resistant 64 Denufosol 64 VentiRx Pharmaceuticals 64 CRLX# 64 Septin9 64 candidate deforolimus 64 OncoGel 64 bortezomib Velcade 64 Phase III Pivotal 64 ErbB1 64 radezolid 64 GTC recombinant human 64 transthyretin TTR 64 certain protein tyrosine 64 Intravenous CP 64 pioglitazone HCl 64 PDX pralatrexate 64 angiogenesis inhibitor 64 non resectable metastatic 64 Phase III Clinical Trial 64 Allovectin 7 64 NASDAQ CGEN announced 64 HuMax CD4 64 highly selective endothelin 64 include PLX IBD 64 Atripla combines 64 Bortezomib 64 Etoposide 64 TRC# 64 proprietary PharmacoSurgery ™ 64 hypoxia activated prodrug 64 Commence Phase 64 NB S# strontium malonate 64 ImmunoBody ® 64 DGAT1 inhibitors 64 Plicera 64 topical gel containing 64 Elvitegravir 63 MEK inhibitors 63 AGE Crosslink Breaker 63 Fleximer R 63 Nutra Pharma wholly owned 63 ribavirin Copegus ® 63 IMiDs ® compound 63 R roscovitine CDK cyclin 63 Copegus ® 63 JAK2 Inhibitor 63 NUVIGIL ® 63 Lixivaptan 63 Vitrasert R 63 humanized therapeutic 63 TOCOSOL Camptothecin 63 Bavituximab 63 Vaccine Adjuvant 63 nucleotide analog 63 Pivotal Study 63 Pafuramidine 63 TLR agonists 63 Anticalin ® 63 pegylated 63 NXL# 63 gemcitabine chemotherapy 63 dexpramipexole 63 FOLFOX6 63 Potassium Chloride Sodium Ascorbate 63 davunetide intranasal AL 63 retapamulin 63 Complicated Skin 63 generation DACH Platinum 63 Cethromycin 63 octreotide acetate 63 6 sulfatase 63 LHRH receptor positive 63 JAK Inhibitor 63 HemosIL 63 inhibitor PPI 63 Tarvacin 63 Epanova 63 complement inhibitor eculizumab 63 Taxol ® 63 Parathyroid Hormone 63 GLYX 63 memantine HCl 63 mGluR2 positive 63 BYETTA ® 63 phase IIa clinical 63 Interferon Beta 63 bevacizumab Avastin 63 Liprotamase 63 TLR9 agonist 63 Solzira ™ 63 defensin mimetic antibiotic 63 SERMs 63 estrogen receptor antagonist 63 Disease IBD 63 TRIOLEX ™ 63 platform HDL Mimetic 63 BiTE R 63 Sphingomab 63 fibrin derived 63 topoisomerase II inhibitor 63 TM Aganocide 63 initiated Phase 1b 63 hyperphenylalaninemia HPA due 63 bendamustine HCl 63 irreversible inhibitor 63 Lisofylline 63 Aganocide R 63 Pathway Inhibitor 63 ProMune 63 Phase Ib clinical trials 63 Nanobody 63 ELND-#/AZD-# 63 Previously Treated 63 Cardio Vascu Grow 63 phase IIb clinical 63 modulator SERM 63 dopamine D2 63 chimeric monoclonal antibody 63 GEM OS2 63 Gemzar ® 63 NanoTab 63 oral beclomethasone dipropionate 63 Completes Enrollment 63 Eraxis 63 PEGASYS ® 63 using Crucell PER.C6 63 taxane resistant 63 AzaSite Xtra 63 Interferon alpha 63 evaluating satraplatin 63 Serdaxin ® 63 taxane derivative 63 plus prednisone prednisolone 63 exon skipping 63 PARI Pharma GmbH 63 III EGFRvIII 63 Lenalidomide 63 hematological cancers 63 proteasome inhibitors 63 elacytarabine 63 histone deacetylase HDAC 63 cisplatin gemcitabine 63 GRNCM1 63 novel DACH platinum 63 Vascugel ® 63 UsiRNAs 63 Solulin 63 rhIL 7 63 mitiglinide 63 DUROS 63 Transdermal Patch 63 Linaclotide 63 Belimumab 63 dSLIM 63 Ixempra 63 receptor inhibitor 63 Marqibo TM 63 Inhalation Solution 63 RhuDex 63 MEK inhibitor 63 Capesaris 63 anti atherothrombotic 63 selective immunoproteasome inhibitor 63 novel orally bioavailable 63 5alpha reductase 63 Cerebril TM 63 PrevOnco ™ 63 ara C 63 Thiovir 63 Lubiprostone 63 Grb 2 63 Nexavar tablets 63 Solazed ™ 63 Civacir 63 pancreatic prostate 63 fusion inhibitor 63 ganetespib 63 Xcytrin R 63 Dalbavancin 63 investigational oral inhibitor 63 sitaxsentan 63 gemcitabine Gemzar 63 clinical trials Archexin 63 JAK inhibitor 63 TTR gene 63 chemosensitizer 63 Therapeutic Competitors Companies 63 epothilones 63 small molecule defensin 63 By JENNIFER LEARN 63 reformulates existing FDA 63 VEGF inhibitors 63 Vitaxin 63 Tesmilifene 63 imatinib Gleevec 63 myelodysplastic myeloproliferative diseases 63 Platinol ® cisplatin 63 IMiDs R 63 LAB CGRP 63 Certolizumab pegol 63 ThermoDox R 63 octreotide implant 63 Aurexis 63 Pruvel TM 63 Cloretazine 63 SNT MC# 63 Transdrug ® nanoparticle 63 psoriasis rheumatoid arthritis 63 Veronate R 63 Solazed 63 successfully commercialize Iluvien 63 BCR ABL inhibitors 63 Anthracycline 63 Antigenics QS 63 Pharmacokinetics PK 63 proprietary Vascular Targeting 63 non peptidic protease 63 UltiMAb ® 63 CysDisplay R 63 transdermal spray 63 Pirfenidone 63 RECOTHROM R 63 huN# DM1 63 Prodarsan R 63 Gleevec resistant 63 selective estrogen receptor modulator 63 Rebif ® 63 Monoclonal antibody 63 phenylalanine ammonia lyase 63 stage IIIb IV 63 BCR ABL inhibitor 63 RNA antagonist 63 INCB# [003] 63 Empatic ™ 63 HDAC Inhibitor 63 Iloperidone 63 potent antiproliferative 63 Augment TM 63 evaluating bafetinib 63 Copegus R 63 factor VIIa 63 technology PolyActive ® 63 Traficet EN 63 infectious diseases autoimmune diseases 63 PrevOnco 63 Initiates Clinical Trial 63 Talabostat 63 PHRM 63 PSN# [002] 63 QuadraSphere 63 peripherally acting 63 vinca alkaloids 63 uricase 63 selective inverse agonist 63 cutaneous T 63 sapropterin dihydrochloride 63 CTAP# Injection 63 hereditary emphysema 63 liposome encapsulated 63 hormone LHRH antagonist 63 Sudhir Agrawal D.Phil 63 GLP1 INT TM 63 PLK1 SNALP 63 OncoVex 63 Cloretazine VNP#M 63 adecatumumab MT# 63 nephropathic cystinosis 63 urethral bulking agent 63 5 HT3 antagonist 63 #D#C# 63 Ad5FGF 4 63 Nektar proprietary 63 PGL#

Back to home page